Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 27,000 KRW
Change Today -800.00 / -2.88%
Volume 530.3K
As of 2:24 AM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

hans biomed corp (042520) Snapshot

Open
27,150
Previous Close
27,800
Day High
28,500
Day Low
26,300
52 Week High
07/6/15 - 28,500
52 Week Low
08/11/14 - 12,600
Market Cap
266.2B
Average Volume 10 Days
529.9K
EPS TTM
412.70
Shares Outstanding
9.9M
EX-Date
09/29/14
P/E TM
65.4x
Dividend
100.00
Dividend Yield
0.37%
Current Stock Chart for HANS BIOMED CORP (042520)

Related News

No related news articles were found.

hans biomed corp (042520) Related Businessweek News

No Related Businessweek News Found

hans biomed corp (042520) Details

Hans Biomed Corporation develops and manufactures medical materials and ingredients for medications in South Korea. It offers allograft tissues, such as bone transplant products, which are used for patients with various settings, including fractures from physical force or pathological fractures, in neurosurgery, orthopedic surgery or dentistry, restoration of the bone removed due to tumors, treatment of periodontal membrane disease, and restoration of the jaw or facial damage, as well as dental bone transplantation. The company’s allograft tissues are also used to recover and regenerate damaged skin with applications in burns, bed sores, diabetic ulcers, long-standing ulcers, cartilage damage, trauma patients, amputation patients, and plastic surgery patients. In addition, it offers silicone polymer products comprising silicone breast implants used for breast augmentation and reconstruction; scar treatment sheets that are used for the treatment and prevention of hypertrophic scars and keloid scars; and silicone blocks. Further, the company provides medical devices consisting of face lifting threads, and hair transplant devices and transplant needles. Additionally, it offers self skin cell treatment agents; and pharmacological agent impregnated bone fillers that are used in patients with fractures due to osteoporosis. It exports its products to 20 countries worldwide. The company was formerly known as Hans Medical Corp. and changed its name to Hans Biomed Corporation in 2000. Hans Biomed Corporation was founded in 1993 and is headquartered in Seoul, South Korea.

Founded in 1993

hans biomed corp (042520) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hans biomed corp (042520) Key Developments

Hans Biomed Corporation, Annual General Meeting, Dec 29, 2014

Hans Biomed Corporation, Annual General Meeting, Dec 29, 2014., at 09:00 Korea Standard Time. Location: Hans Daeduk Institute Conference Room. Agenda: To consider the financial statements and the cash dividend; to consider the and Re-Appointment of cases (term expired) 2-1 bill; to consider appointment of directors; and to approve the remuneration.

Hans Biomed Corporation, Board Meeting, Dec 08, 2014

Hans Biomed Corporation, Board Meeting, Dec 08, 2014.

Hans Biomed Corporation, Special/Extraordinary Shareholders Meeting, Jun 27, 2014

Hans Biomed Corporation, Special/Extraordinary Shareholders Meeting, Jun 27, 2014., at 10:00 Korea Standard Time. Location: Beongil 64 1628 Daejeon Daejeon Planetary Institute. Agenda: To consider election of Directors.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
042520:KS 27,000.00 KRW -800.00

042520 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 042520.
View Industry Companies
 

Industry Analysis

042520

Industry Average

Valuation 042520 Industry Range
Price/Earnings 66.7x
Price/Sales 11.4x
Price/Book 6.4x
Price/Cash Flow 69.0x
TEV/Sales 11.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HANS BIOMED CORP, please visit www.hansbiomed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.